AZ-23 is a potent, ATP-competitive Trk kinase inhibitor, specifically targeting TrkA, TrkB, and TrkC receptors to modulate neurotrophin signaling. Extensively utilized in biochemical research, this compound… Read more
AZ-23 is a potent, ATP-competitive Trk kinase inhibitor, specifically targeting TrkA, TrkB, and TrkC receptors to modulate neurotrophin signaling. Extensively utilized in biochemical research, this compound facilitates detailed investigations into pain sensitization models and kinase-dependent biological pathways. This category features the parent compound alongside a selection of critical analytical tools, including its maleate salt form, specific nitroso impurities, and stable isotope labelled standards. These high-quality reference standards are essential for pharmaceutical laboratories performing rigorous impurity profiling and method validation. By utilizing these characterized materials, researchers can ensure accurate quantitative analysis and maintain strict quality control during the development and evaluation of kinase inhibitor drug candidates. Whether determining assay sensitivity or conducting stability testing, these compounds provide the precision required for reliable analytical outcomes in modern drug discovery and development settings.